Ask the Accelerators is a series highlighting the perspectives and work of organizations and individuals participating in the COVID-19 Evidence Accelerator. Organized by the Reagan-Udall Foundation for the U.S. Food and Drug Administration (FDA) and Friends of Cancer Research, the COVID-19 Evidence Accelerator joins leaders in the health care data and analytics space to explore how real-world data (RWD) can inform key COVID-19 research questions. 

Diagnostic testing is a critical piece of the COVID-19 puzzle—not only to diagnose those presenting symptoms and provide the appropriate treatment, but also to identify asymptomatic individuals in an effort to curb the spread of disease.

Additionally, as COVID-19 vaccines become available, neutralizing antibody tests will be key to developing a vaccine distribution strategy by illuminating who already has antibodies, and who needs a vaccine first.

Read more